All news
-
4 Oct 2023
Neuroimmune crosstalk in early Alzheimer’s disease – PhD interview with Megg Garcia-Ryde
Megg Garcia-Ryde’s thesis sheds light on the early pathological processes in Alzheimer’s disease and the interplay between neurons and microglia as the disease evolves. October 10,...
-
25 Sep 2023
Clinical imaging methods – A special interest group
Imaging methods are valuable tools for understanding neurodegenerative diseases and monitoring the therapeutic effects of new treatments. That is why MultiPark researchers with exp...
-
22 Sep 2023
Genetic tools for studying Parkinson’s Disease – PhD interview with Martino Avallone
Martino Avallone spent the past four years developing tools for mapping gene expression and proteins in the brain to investigate basic biological questions and to elucidate the mol...
-
19 Sep 2023
How psychedelic drugs affect a rat’s brain
Researchers at Lund University have developed a technique for simultaneously measuring electrical signals from 128 areas of the brain in awake rats. They have then used the informa...
-
12 Sep 2023
MultiPark’s coordinator awarded the Bengt Falck Prize in Neuroscience
Through her work, Professor Cenci Nilsson has developed preclinical models mimicking the symptoms of Parkinson’s disease and L-DOPA-induced dyskinesia, exploiting these models to d...
-
4 Sep 2023
Electrotherapy without surgery
Researchers at Lund and Gothenburg Universities have successfully developed temporary, organic electrodes that can be seamlessly integrated into biological systems. The method, now...
-
24 Aug 2023
Lewy body disease can be detected before symptoms
Lewy body disease is the second most common neurodegenerative disease after Alzheimer's disease. A research group from Lund University has now shown that the disease can be detecte...
-
15 Aug 2023
New Study Reveals Astrocytes' Role in Frontotemporal Dementia
One of Multipark's associated research groups has published a new study that reveals the role of astrocytes in the development of frontotemporal dementia (FTD). Their findings, now...
-
11 Jul 2023
Summer greetings from MultiPark at the World Parkinson Congress
Summer is the right period for recharging our batteries through vacations and travels. It also seems to be an attractive time to organize scientific conferences… Here are some warm...
-
5 Jul 2023
Cell replacement therapy for Parkinson's Disease – Ph.D. interview with Fredrik Nilsson
Fredrik Nilsson defended his Ph.D. thesis on May 10, 2023. For the last four years, he has explored the use of patient-specific cells in cell replacement therapy for Parkinson's di...
-
27 Jun 2023
Exploring the Role of 'Jumping Genes' in X-Linked Dystonia-Parkinsonism
New research is underway at Lund University, led by Dr. Vivien Horvath, a postdoctoral researcher at Lund Stem Cell Center. Supported by a new grant from the Collaborative Center f...
-
7 Jun 2023
Fluid biomarkers – A special interest group
Thanks to the recent development of diagnostic tools based on blood biomarkers linked to Alzheimer’s, it is possible to predict whether an individual will develop the disease. Ther...
-
2 Jun 2023
Brain in Picture – The winning photo!
In April, the young MultiPark working group organized a photo competition entitled "Brain in Picture". The external jury has had a hard time choosing, but now, they have appointed ...
-
29 May 2023
Acquired brain injuries – A special interest group
Recent studies indicate that acquired brain injuries, such as traumatic brain injury, trigger potentially harmful responses that may lead to neurodegenerative pathology. “Acquired ...
-
17 May 2023
Superstars coming to Lund for pharmaceutical symposium sponsored by MultiPark
Several Nobel laureates, renowned scientists, and successful biotech entrepreneurs are coming to Lund in May to participate in the Lund Spring Symposium, an international pharmaceu...
-
13 Apr 2023
Double success for MultiPark research groups in prestigious EU grant round
Three researchers at Lund University, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further devel...
-
11 Apr 2023
WORLD PARKINSON's DAY: Transplantations for Parkinson's disease – A time travel
In the early 1950s, no one knew what caused Parkinson's disease. Then, Arvid Carlsson's discovery of dopamine opened the door to world-leading transplantations for Parkinson's pati...
-
28 Mar 2023
Genetics of Neurodegenerative Diseases – A special interest group
Genetics are one of the keys to understanding neurodegenerative disease. That is why MultiPark researchers with expertise in genetics gather across research groups. Genetics of neu...
-
20 Mar 2023
Genes and environment in PD – PhD interview with Kajsa Brolin
Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank s...
-
16 Mar 2023
Meet Our Scientists! – New podcast by young MultiPark researchers
Looking for the next step in your career? In need of some scientific inspiration? Or are you just curious about what MultiPark´s senior researchers are doing and their professional...